CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- 8-K Event Shareholder vote results
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure
- 8-K/A Event Acquisition or sale completed · Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Auditor change · Shareholder vote results · Regulation FD disclosure · Other events
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results · Other events
- 10-Q Report Quarterly Report
Page 2 of 3 · 49 filings